Daxor's blood volume analysis technology accelerates market penetration with three new facility adoptions

Continued integration of daxor's ezbva lab service and on-site analyzers fuels positive outlook oak ridge, tn, july 22, 2025 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, announces the expansion of its blood volume analysis (bva) technology into three new hospitals, a testament to the growing recognition of bva's essential role in improving lives and reducing healthcare costs. this growth is driven by a combination of daxor's state-of-the-art clia-certified ezbva lab service, which delivers on-demand, next-day blood volume analysis results, and an on-site placement of its blood volume analyzer.
DXR Ratings Summary
DXR Quant Ranking